|Datasheet||Specific References||Reviews||Related Products||Protocols|
|ORF Clone of Homo sapiens synuclein, alpha (non A4 component of amyloid precursor) DNA.|
|PD1, NACP, PARK1, PARK4, MGC110988, SNCA|
|Identical with the Gene Bank Ref. ID sequence.|
|Whatman FTA elute card (Cat: WB120410) contains 5-10 μg of plasmid.|
|The Whatman FTA elute card can be stored at room temperature for three months under dry condition.|
The pGEM-T is 3kb in length, and contains the amplicin resistance gene, conferring selection of the plasmid in E. coli, and the ori site which is the bacterial origin of replication. The plasmid has multiple cloning sites as shown below. The coding sequence was inserted by TA cloning. Many E. coli strains are suitable for the propagation of this vector including JM109, DH5α and TOP10.
The coding sequence can be easily obtained by digesting the vector with proper restriction enzyme(s). The coding sequence can also be amplified by PCR with M13 primers, or primer pair SP6 and T7.
|Human SNCA Gene cDNA Clone (full-length ORF Clone), expression ready, FLAG-tagged||HG12093-G-F|
|Human SNCA Gene cDNA Clone (full-length ORF Clone), expression ready, His-tagged||HG12093-G-H|
|Human SNCA Gene cDNA Clone (full-length ORF Clone), expression ready, Myc-tagged||HG12093-G-M|
|Human SNCA Gene cDNA Clone (full-length ORF Clone), expression ready, untagged||HG12093-G-N|
|Human SNCA Gene cDNA Clone (full-length ORF Clone), expression ready, HA-tagged||HG12093-G-Y|
|Product name||Product name|
Alpha-Synuclein (alpha-Syn), also known as NACP or SNCA, exists as at least two structural isoforms: one is helix-rich, membrane-bound form that both the N- and C-terminal regions of alpha-synuclein are tightly associated with membranes and the other is disordered, cytosolic form. Synuclein is found predominantly in the presynaptic termini, in both free or membrane-bound forms. SNCA is extensively localized in nucleus of neurons. It has been shown that alpha-Synuclein was highly expressed in the mitochondria in olfactory bulb, hippocampus, striatum, and thalamus, where the cytosolic alpha-Synuclein was also rich. Normally the unstructured soluble type of alpha-synuclein can aggregate to form insoluble fibrils in pathological conditions characterized by Lewy bodies, such as Parkinson's disease, dementia with Lewy bodies and multiple system atrophy. SNCA abnormality and mitochondrial deficiency are two major changes in the brain of patients with Parkinson's disease (PD). In addition, alpha-synuclein is an abundant component of Lewy bodies in sporadic Parkinson's disease and diffuse Lewy body disease.